Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth E Palmer

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Scientific Reports|June 4, 2025
NMDA receptor antagonists mitigate COVID-19-induced neuroinflammation and improve survival in a mouse modelEmily R Prantzalos, Jane P Chesser, Judy Songrady Logan, et al.
Scientific Reports|May 10, 2023
A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4<sup>+</sup> cell distribution in the human rectal mucosaMathias Franzén Boger, Nora Benhach, Tyra Hasselrot, et al.
American Journal of Public Health|May 18, 2023
Stratified Simple Random Sampling Versus Volunteer Community-Wide Sampling for Estimates of COVID-19 PrevalenceRachel J Keith, Rochelle H Holm, Alok R Amraotkar, et al.
Journal of Virology|December 25, 2009
Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family CoronaviridaeBarry R O'Keefe, Barbara Giomarelli, Dale L Barnard, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2009
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide componentBarry R O'Keefe, Fakhrieh Vojdani, Viviana Buffa, et al.
Scientific Reports|December 4, 2019
Impact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: In situ analyses of epithelial and immune cell markers in rectal mucosaGökçe Günaydın, Gabriella Edfeldt, David A Garber, et al.
Vaccines|June 27, 2025
Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville CohortLalit Batra, Divyasha Saxena, Triparna Poddar, et al.
Plant Biotechnology Journal|June 2, 2010
Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systemsGregory P Pogue, Fakhrieh Vojdani, Kenneth E Palmer, et al.
Scientific Reports|August 4, 2021
Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patientsEric C Rouchka, Julia H Chariker, Brian Alejandro, et al.
ACS ES&T Water|August 8, 2023
Public Awareness of and Support for the Use of Wastewater for SARS-CoV-2 Monitoring: A Community Survey in Louisville, KentuckyRochelle H Holm, J Michael Brick, Alok R Amraotkar, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Scientific Reports|June 4, 2025
NMDA receptor antagonists mitigate COVID-19-induced neuroinflammation and improve survival in a mouse modelEmily R Prantzalos, Jane P Chesser, Judy Songrady Logan, et al.
Scientific Reports|May 10, 2023
A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4<sup>+</sup> cell distribution in the human rectal mucosaMathias Franzén Boger, Nora Benhach, Tyra Hasselrot, et al.
American Journal of Public Health|May 18, 2023
Stratified Simple Random Sampling Versus Volunteer Community-Wide Sampling for Estimates of COVID-19 PrevalenceRachel J Keith, Rochelle H Holm, Alok R Amraotkar, et al.
Journal of Virology|December 25, 2009
Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family CoronaviridaeBarry R O'Keefe, Barbara Giomarelli, Dale L Barnard, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2009
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide componentBarry R O'Keefe, Fakhrieh Vojdani, Viviana Buffa, et al.
Scientific Reports|December 4, 2019
Impact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: In situ analyses of epithelial and immune cell markers in rectal mucosaGökçe Günaydın, Gabriella Edfeldt, David A Garber, et al.
Vaccines|June 27, 2025
Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville CohortLalit Batra, Divyasha Saxena, Triparna Poddar, et al.
Plant Biotechnology Journal|June 2, 2010
Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systemsGregory P Pogue, Fakhrieh Vojdani, Kenneth E Palmer, et al.
Scientific Reports|August 4, 2021
Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patientsEric C Rouchka, Julia H Chariker, Brian Alejandro, et al.
ACS ES&T Water|August 8, 2023
Public Awareness of and Support for the Use of Wastewater for SARS-CoV-2 Monitoring: A Community Survey in Louisville, KentuckyRochelle H Holm, J Michael Brick, Alok R Amraotkar, et al.
Pageof 7